Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VARUN MALHOTRA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1649590746
CMS profile
865595
Location
JOHNSTOWN, PA

General Payments · PY2018–2024

$4,618.21

  • Reported across 181 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$882.43

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $753.03 28
Education $129.40 8

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $713.08 24
PY2019 $788.95 38
PY2020 $359.64 10
PY2021 $192.18 6
PY2022 $483.92 19
PY2023 $1,198.01 48
PY2024 $882.43 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $18.60 02/13/2024 Food and Beverage Undisputed 01/23/2026 1093900743 CMS
Amgen Inc. $25.27 02/27/2024 Food and Beverage Undisputed 01/23/2026 1117618150 CMS
Amgen Inc. $22.38 07/23/2024 Food and Beverage Undisputed 01/23/2026 1115895518 CMS
Ardelyx, Inc. $27.10 06/11/2024 Food and Beverage Undisputed 01/23/2026 1146693726 CMS
AstraZeneca Pharmaceuticals LP $13.44 06/04/2024 Food and Beverage Undisputed 01/23/2026 1104747795 CMS
AstraZeneca Pharmaceuticals LP $22.51 07/09/2024 Food and Beverage Undisputed 01/23/2026 1104475632 CMS
AstraZeneca Pharmaceuticals LP $19.80 09/11/2024 Food and Beverage Undisputed 01/23/2026 1104688326 CMS
AstraZeneca Pharmaceuticals LP $18.48 10/22/2024 Food and Beverage Undisputed 01/23/2026 1104756616 CMS
AstraZeneca Pharmaceuticals LP $15.94 11/12/2024 Food and Beverage Undisputed 01/23/2026 1105258003 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.14 01/04/2024 Food and Beverage Undisputed 01/23/2026 1086192142 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.33 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086125676 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.75 07/16/2024 Food and Beverage Undisputed 01/23/2026 1086153041 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.14 08/13/2024 Food and Beverage Undisputed 01/23/2026 1086171150 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.24 08/29/2024 Food and Beverage Undisputed 01/23/2026 1086196084 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.80 11/06/2024 Food and Beverage Undisputed 01/23/2026 1086218075 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $113.15 02/15/2024 Food and Beverage Undisputed 01/23/2026 1118095304 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.81 04/30/2024 Food and Beverage Undisputed 01/23/2026 1118095302 CMS
Kyowa Kirin, Inc. $26.73 03/20/2024 Food and Beverage Undisputed 01/23/2026 1127045105 CMS
Lilly USA, LLC $20.33 09/25/2024 Food and Beverage Undisputed 01/23/2026 1135451607 CMS
Novartis Pharmaceuticals Corporation $23.71 09/03/2024 Food and Beverage Undisputed 01/23/2026 1087117698 CMS
Novartis Pharmaceuticals Corporation $32.89 09/11/2024 Food and Beverage Undisputed 01/23/2026 1087117700 CMS
Novo Nordisk Inc $22.66 06/18/2024 Food and Beverage Undisputed 01/23/2026 1096679299 CMS
OPKO Pharmaceuticals, LLC $17.10 02/23/2024 Education Undisputed 01/23/2026 1112846890 CMS
OPKO Pharmaceuticals, LLC $19.17 03/01/2024 Education Undisputed 01/23/2026 1112846892 CMS
OPKO Pharmaceuticals, LLC $19.86 07/30/2024 Education Undisputed 01/23/2026 1112846894 CMS
OPKO Pharmaceuticals, LLC $19.52 10/16/2024 Education Undisputed 01/23/2026 1112846896 CMS
Otsuka America Pharmaceutical, Inc. $22.51 02/06/2024 Food and Beverage Undisputed 01/23/2026 1118934682 CMS
Otsuka America Pharmaceutical, Inc. $25.53 09/16/2024 Food and Beverage Undisputed 01/23/2026 1118934684 CMS
Takeda Pharmaceuticals U.S.A., Inc. $41.65 07/25/2024 Food and Beverage Undisputed 01/23/2026 1137628191 CMS
Travere Therapeutics, Inc. $3.08 03/05/2024 Education Undisputed 01/23/2026 1149911927 CMS
Travere Therapeutics, Inc. $16.89 03/05/2024 Education Undisputed 01/23/2026 1149911931 CMS
Travere Therapeutics, Inc. $16.89 03/20/2024 Education Undisputed 01/23/2026 1149911935 CMS
Travere Therapeutics, Inc. $16.89 06/25/2024 Education Undisputed 01/23/2026 1149911939 CMS
Travere Therapeutics, Inc. $35.59 06/25/2024 Food and Beverage Undisputed 01/23/2026 1149911943 CMS
Travere Therapeutics, Inc. $42.81 12/05/2024 Food and Beverage Undisputed 01/23/2026 1149911947 CMS
Vifor Pharma, Inc. $24.74 03/18/2024 Food and Beverage Undisputed 01/23/2026 1124046663 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.